Find comprehensive information on Thyroid Cancer diagnosis including ICD-10 codes C73, differential diagnosis, clinical documentation requirements, treatment options, and pathology reports. Learn about the latest medical coding guidelines for Thyroid Cancer, including differentiated thyroid cancer, medullary thyroid cancer, anaplastic thyroid cancer, and follicular thyroid cancer. This resource provides essential information for healthcare professionals, medical coders, and patients seeking to understand Thyroid Cancer diagnosis, staging, and management.
Also known as
Malignant neoplasm of thyroid gland
Cancers originating in the thyroid gland.
Secondary malignant neoplasm of thyroid
Cancer that has spread to the thyroid from another site.
Personal history of malignant neoplasm of thyroid
Patient has a history of thyroid cancer, now inactive or resolved.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the thyroid cancer papillary?
When to use each related code
| Description |
|---|
| Thyroid cancer |
| Thyroid nodule |
| Goiter |
Incorrect coding of thyroid cancer histology (papillary, follicular, medullary, anaplastic) impacts staging and treatment, leading to inaccurate reimbursement.
Missing documentation of lateral lymph node involvement can affect staging and treatment planning, impacting medical coding accuracy and reimbursement.
Incomplete or inaccurate tumor size documentation affects staging and can trigger coding audits, resulting in claims denials and lost revenue.
Q: What are the most effective diagnostic imaging modalities for differentiating benign thyroid nodules from thyroid cancer in patients with indeterminate cytology?
A: When thyroid nodule cytology is indeterminate, differentiating benign nodules from malignancy requires further investigation. High-resolution ultrasound, often combined with elastography, plays a crucial role in assessing nodule characteristics such as composition, echogenicity, margins, and vascularity. Suspicious ultrasound features may warrant further evaluation with contrast-enhanced ultrasound or magnetic resonance imaging (MRI), which can provide additional information regarding tissue characteristics and vascular patterns. Consider implementing a multiparametric approach incorporating these imaging modalities to improve the diagnostic accuracy and inform decisions regarding fine-needle aspiration biopsy or surgical intervention. Explore how combining ultrasound features with cytology results can refine risk stratification in these patients. Learn more about the ATA guidelines for the management of thyroid nodules and differentiated thyroid cancer.
Q: How do I manage a patient with elevated serum calcitonin but negative neck ultrasound for thyroid cancer?
A:
Patient presents with concerns regarding thyroid cancer. Chief complaints may include palpable thyroid nodule, neck swelling, dysphagia, hoarseness, or voice changes. Pertinent history includes family history of thyroid cancer, history of radiation exposure to the head and neck, and any prior thyroid nodules or biopsies. Physical examination reveals thyroid gland characteristics including size, shape, consistency, and presence of any nodules. Nodule characteristics such as size, location, mobility, and tenderness are documented. Differential diagnoses include benign thyroid nodules, thyroiditis, and other head and neck malignancies. Diagnostic workup may include thyroid ultrasound, fine-needle aspiration biopsy (FNAB), blood tests for thyroid function (TSH, T3, T4), and thyroglobulin levels. If FNAB reveals malignancy, further imaging such as CT scan or MRI of the neck and chest may be indicated for staging. Treatment options for thyroid cancer include surgical resection (thyroidectomy), radioactive iodine therapy, thyroid hormone suppression therapy, and targeted therapy. The specific treatment plan will be determined based on the type and stage of thyroid cancer, patient preferences, and overall health status. Patient education regarding the diagnosis, treatment options, potential complications, and follow-up care is essential. Follow-up appointments will be scheduled for monitoring of thyroid function, thyroglobulin levels, and surveillance for recurrence. Medical coding and billing will be performed using appropriate ICD-10 codes for thyroid cancer (C73) and CPT codes for procedures performed, such as FNAB (10022) and thyroidectomy (60200-60271).